Status:
COMPLETED
(PEKK) Framework for Mandibular Implant-supported Complete Fixed Prostheses
Lead Sponsor:
Fatma mahanna
Conditions:
Bone Loss
Peri-Implantitis
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
This clinical study aims to evaluate the effect of using PEKK (Pekkton) framework in mandibular implant-supported complete fixed dental prostheses with All-on-four treatment concept on peri-implant ti...
Detailed Description
The aim of this clinical study is to evaluate the effect of using PEKK (Pekkton) framework in mandibular implant-supported complete fixed dental prostheses with All-on-four treatment concept on peri-i...
Eligibility Criteria
Inclusion
- Maxillary and mandibular alveolar ridges were covered with healthy, firm, relatively even thickness and even compressible mucosa and free from any signs of inflammation or flabbiness.
- Patients had completely edentulous maxillary and mandibular ridges with sufficient mandibular bone height not less than 15 mm in the interforaminal area and at least 12mm posteriorly
- All patients had sufficient inter-arch space
- All patients complained of insufficient retention and stability of their conventional mandibular dentures.
- All patients were of Angel's class I maxillo-mandibular relationship.
Exclusion
- Patients with absolute contraindications for implant placement, such as active cancer and diseases of the immune system.
- Patients with metabolic diseases that are directly related to bone resorption, such as uncontrolled diabetes, osteoporosis, and hyperparathyroidism.
- Patients with general contraindications for surgical procedures, such as hematologic diseases, hepatic patients, patients with bleeding disorders, and serious problems with coagulation.
- Patients with a history of irradiation of the head and neck region or chemotherapy in the last 3 years were also excluded.
- Patients with relative contraindications such as a history of parafunctional habits (such as bruxism and clenching), smoking, alcoholism, and patients with any physical reasons that could affect follow-up.
- Patients with local contraindications for implant placement, such as localized bone defects.
Key Trial Info
Start Date :
May 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2023
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06164990
Start Date
May 10 2022
End Date
November 10 2023
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of dentistry, mansoura university
Al Mansurah, Dakahlia Governorate, Egypt, 35511